Tesla's Disappointing Q1 Performance and Future Plans

11min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter delves into Tesla's lackluster Q1 results, missed profit estimates, and falling sales, despite plans to launch new, more affordable models. It also explores Tesla's vision for self-driving cars and ride-hailing services, positioning itself as an AI and robotics company. The chapter discusses the valuation perspectives on Tesla stock, regulatory challenges in self-driving technology, and the FTC's ruling to ban non-compete agreements for American workers.

Episode 308: Neal and Toby dive into Tesla’s Q1 earnings report which certainly had its ups and downs with the announcement of a new affordable model despite having an abysmal sales performance. Then, the FTC just banned noncompete agreements because it believes it could raise the earnings of Americans. Next, Meta just released its chat bot and wants to make sure everyone knows about it. Meanwhile, there could be a new miracle drug that is a fraction of the cost of Ozempic. Also, a Finnish company wants to solve the world’s coffee supply problem with AI. Lastly, Armand Duplantis breaks his own pole vaulting record and there’s a cash incentive why.

00:00 - Intro

2:45 - Tesla’s optimistic future

7:00 - FTC bans noncompete agreements

10:30 - Meta AI is here

13:45 - Newest miracle drug for cheap?

18:00 - Cup of AI joe

21:00 - Pole vault your incentives

Get your Morning Brew Daily Merch HERE: https://shop.morningbrew.com/products/morning-brew-daily-sweatshirt?utm_medium=multimedia&utm_source=podcast&utm_campaign=mbd&utm_content=shownotes

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD

Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Learn more about your ad choices. Visit megaphone.fm/adchoices